-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, AQ4lJg/pxjbmaxELtDAYVxkAMhyD1ezS4zBloXnEVl8RfT1B1eGvS/HPV4HSDYSc j+OAxeoU1xOscKbBhQyldg== 0001035704-03-000104.txt : 20030213 0001035704-03-000104.hdr.sgml : 20030213 20030213143304 ACCESSION NUMBER: 0001035704-03-000104 CONFORMED SUBMISSION TYPE: SC 13D PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20030213 SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: HEI INC CENTRAL INDEX KEY: 0000351298 STANDARD INDUSTRIAL CLASSIFICATION: SEMICONDUCTORS & RELATED DEVICES [3674] IRS NUMBER: 410944876 STATE OF INCORPORATION: MN FISCAL YEAR END: 0831 FILING VALUES: FORM TYPE: SC 13D SEC ACT: 1934 Act SEC FILE NUMBER: 005-33908 FILM NUMBER: 03558652 BUSINESS ADDRESS: STREET 1: 1495 STEIGER LAKE LN STREET 2: P O BOX 5000 CITY: VICTORIA STATE: MN ZIP: 55386 BUSINESS PHONE: 9524432500 MAIL ADDRESS: STREET 1: P O BOX 5000 STREET 2: 1495 STEIGER LAKE LANE CITY: VICTORIA STATE: MN ZIP: 55386 FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: COLORADO MEDTECH INC CENTRAL INDEX KEY: 0000720013 STANDARD INDUSTRIAL CLASSIFICATION: ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS [3845] IRS NUMBER: 840731006 STATE OF INCORPORATION: CO FISCAL YEAR END: 0630 FILING VALUES: FORM TYPE: SC 13D BUSINESS ADDRESS: STREET 1: 6175 LONGBOW DR CITY: BOULDER STATE: CO ZIP: 80301 BUSINESS PHONE: 3035302660 MAIL ADDRESS: STREET 1: 6175 LONGBOW DRIVE CITY: BOULDER STATE: CO ZIP: 80301 FORMER COMPANY: FORMER CONFORMED NAME: CYBERMEDIC INC DATE OF NAME CHANGE: 19920703 SC 13D 1 d03145sc13d.htm SCHEDULE 13D sc13d
 

OMB APPROVAL
OMB Number: 3235-0145
Expires: December 31, 2005
Estimated average burden
hours per response...11


UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

SCHEDULE 13D

Under the Securities Exchange Act of 1934
(Amendment No. )*

HEI, Inc.

(Name of Issuer)

Common Stock, par value $0.05 per share

(Title of Class of Securities)

404160103

(Cusip Number)

Peter J. Jensen, General Counsel
Colorado MEDtech, Inc.
345 S. Francis St., Unit F
P.O. Box 819
Longmont, CO 80502-0819
(303) 530-2660

(Name, Address and Telephone Number of Person
Authorized to Receive Notices and Communications)

January 24, 2003

(Date of Event Which Requires Filing of this Statement)

If the filing person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because of §§240.13d-1(e), 240.13d-1(f) or 240.13d-1(g), check the following box. o

Note: Schedules filed in paper format shall include a signed original and five copies of the schedule, including all exhibits. See §240.13d-7 for other parties to whom copies are to be sent.

* The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter disclosures provided in a prior cover page.

The information required on the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

 

 

             
CUSIP No. 404160103
  1. Name of Reporting Person:
Colorado MEDtech, Inc.		 I.R.S. Identification Nos. of above persons (entities only):
84-0731006
  2. Check the Appropriate Box if a Member of a Group (See Instructions):
    (a) o  
    (b) o  
  3. SEC Use Only:
  4. Source of Funds (See Instructions):
WC, OO
  5. Check if Disclosure of Legal Proceedings Is Required Pursuant to Items 2(d) or 2(e): o
  6. Citizenship or Place of Organization:
Colorado
Number of
Shares
Beneficially
Owned by
Each Reporting
Person With
7. Sole Voting Power:
955,000 shares
8. Shared Voting Power:
n/a
9. Sole Dispositive Power:
955,000 shares
10.Shared Dispositive Power:
n/a
  11.Aggregate Amount Beneficially Owned by Each Reporting Person:
955,000 shares
  12.Check if the Aggregate Amount in Row (11) Excludes Certain Shares (See Instructions):
o
  13.Percent of Class Represented by Amount in Row (11):
13.6%
  14.Type of Reporting Person (See Instructions):
CO

2

 

       
Item 1. Security and Issuer
  The title and class of equity securities to which this statement relates: common stock, par value $0.05 per share, of HEI, Inc. (“Common Stock” or the “Securities”)
The name and address of the principal executive offices of the Issuer: HEI, Inc. 6385 Old Shady Oak Rd., Suite 280, Eden Prairie, MN 55344
 
Item 2.Identity and Background
  This Schedule 13D is filed by Colorado MEDtech, Inc., a Colorado corporation, a developer and manufacturer of medical devices (the “Company”). The Company’s address is: 345 S. Francis Street, Unit F, P.O. Box 819, Longmont, CO 80502-0819.

The Company has not, during the last five years, been convicted in a criminal proceeding.

The Company has not, during the last five years, been party to a civil proceeding of a judicial or administrative body of competent jurisdiction and as a result of such proceeding been subject to a judgment, decree or final order enjoining future violations of, or prohibiting or mandating activities subject to, federal or state securities laws or finding any violation with respect to such laws.

 
Item 3.Source and Amount of Funds or Other Consideration
  The Securities were acquired in a transaction in which the Company transferred certain assets of the Company’s Colorado operations, including cash, to the Issuer. In consideration, the Issuer issued the securities and a subordinated debenture to the Company, and assumed certain liabilities of the Company.
 
Item 4.Purpose of Transaction
  The Securities were acquired as part of consideration in the transaction described in Item 3, above.
(a) The Issuer is obligated under a registration rights agreement to register the Securities. The Company may dispose of the securities before they are registered. The Issuer is also obligated to use commercially reasonable efforts to find a qualified purchaser of the Securities. The Company also holds a right to sell some or all the Securities in any Issuer issuance or sale of common stock.
 
 

3

 

       
Item 5.Interest in Securities of the Issuer
  (a) The Company holds 955,000 shares of Common Stock, representing 13.6% of the outstanding and issued Common Stock.
(b) The Company holds 955,000 shares of the Common Stock individually and has sole voting and dispositive power with regard to those shares.
 
Item 6.Contracts, Arrangements, Understandings or Relationships with Respect to Securities of the Issuer
  The Company and the Issuer have entered into the agreements relating to the Securities as are set forth in Item 4(a).
 
Item 7.Material to Be Filed as Exhibits
  Exhibit 2.1 to the Company’s Form 8-K filed February 10, 2003, is incorporated by reference.
 

4

 

SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.
   
February 13, 2003
 
Colorado MEDtech, Inc.
   
By: /s/ Peter J. Jensen
Name: Peter J. Jensen
Title: Secretary
   

The original statement shall be signed by each person on whose behalf the statement is filed or his authorized representative. If the statement is signed on behalf of a person by his authorized representative (other than an executive officer or general partner of the filing person), evidence of the representative’s authority to sign on behalf of such person shall be filed with the statement: provided, however, that a power of attorney for this purpose which is already on file with the Commission may be incorporated by reference. The name and any title of each person who signs the statement shall be typed or printed beneath his signature.

Attention: Intentional misstatements or omissions of fact
constitute Federal criminal violations (See 18 U.S.C. 1001)

5 -----END PRIVACY-ENHANCED MESSAGE-----